Investigating new pathways of protein kinase G in high blood pressure and heart disease
Novel downstream effectors of protein kinase G in hypertensive disease
This study is looking at how a protein called PKG works in people with high blood pressure and heart failure, especially older adults, to find new ways to improve treatments for these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10815729 on NIH RePORTER |
What this research studies
This research focuses on understanding how protein kinase G (PKG) functions in the context of hypertension and its related complications, particularly heart failure. By examining the mechanisms through which PKG signaling is impaired in patients with high blood pressure, especially older adults, the study aims to identify novel therapeutic targets. The approach involves both laboratory experiments and potential clinical applications to improve treatment strategies for hypertension and heart failure. Patients may benefit from insights that could lead to more effective therapies tailored to their specific conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults suffering from hypertension, particularly those who have not responded well to conventional therapies.
Not a fit: Patients with low blood pressure or those who do not have hypertension or related cardiovascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better manage high blood pressure and reduce the risk of heart failure.
How similar studies have performed: Previous research has shown promise in exploring the role of PKG in cardiovascular health, indicating that this approach could yield significant insights.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Stelzer, Julian — Case Western Reserve University
- Study coordinator: Stelzer, Julian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.